ADIPOQ and Insulin resistance: In conditions such as obesity, aging, insulin resistance, dyslipidemia, or chronic oxidative stress, PVAT undergoes phenotypic switching, adopting a pro-inflammatory profile leading to increased secretion of leptin, IL-6, and TNF-α, while decreasing adiponectin levels.